Advertisement
Canada markets close in 2 hours 47 minutes
  • S&P/TSX

    21,849.23
    -24.49 (-0.11%)
     
  • S&P 500

    5,033.19
    -38.44 (-0.76%)
     
  • DOW

    38,004.31
    -456.61 (-1.19%)
     
  • CAD/USD

    0.7310
    +0.0012 (+0.17%)
     
  • CRUDE OIL

    82.43
    -0.38 (-0.46%)
     
  • Bitcoin CAD

    88,525.44
    -157.51 (-0.18%)
     
  • CMC Crypto 200

    1,391.36
    +8.79 (+0.64%)
     
  • GOLD FUTURES

    2,339.70
    +1.30 (+0.06%)
     
  • RUSSELL 2000

    1,974.36
    -21.07 (-1.06%)
     
  • 10-Yr Bond

    4.7000
    +0.0480 (+1.03%)
     
  • NASDAQ

    15,547.73
    -165.02 (-1.05%)
     
  • VOLATILITY

    16.40
    +0.43 (+2.69%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6807
    -0.0012 (-0.18%)
     

Company News for Nov 10, 2022

  • Shares of Akamai Technologies Inc. AKAM jumped 6.2% after reporting third-quarter 2022 adjusted earnings per share of $1.26, surpassing the Zacks Consensus Estimate of $1.23.

  • Shares of Axon Enterprise Inc. AXON soared 14.6% after posting third-quarter 2022 adjusted earnings per share of $0.60, outpacing the Zacks Consensus Estimate of $0.46.  

  • Globus Medical Inc.’s GMED shares tumbled 4.2% after the company posted third-quarter 2022 adjusted earnings per share of $0.50, missing the Zacks Consensus Estimate of $0.52.

  • Spirit Realty Capital Inc.’s SRC shares gained 2.1% after the company reported third-quarter 2022 adjusted earnings per share of $0.90, beating the Zacks Consensus Estimate of $0.89.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Akamai Technologies, Inc. (AKAM) : Free Stock Analysis Report
 
Globus Medical, Inc. (GMED) : Free Stock Analysis Report
 
Spirit Realty Capital, Inc. (SRC) : Free Stock Analysis Report
 
Axon Enterprise, Inc (AXON) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research